Sickle Cell Disease (Drepanocytosis)

Active ingredient of organically certified origin consisting of alpha-linolenic acid derived from linseeds. Alpha-linolenic acid 18:n3 is a polyunsaturated fatty acid. The final proprietary formulation is manufactured using a microreactor and the encapsulation process results in a premium product protected against oxidation with long term stability when stored at room temperature.

Key Characteristics:

anti-inflammatory
vasodilatory
improves blood flowability thereby reducing the risk of thromboembolic complications

Key characteristics of alpha-linolenic acid in sickle cell disease when taken at daily doses and for a duration as recommended by health care professionals include but are not limited to the above

References:

Stivala S, Gobatto S, Bonetti N, Camici GG, Lüscher TF, Beer JH
Dietary alpha-linolenic acid reduces platelet activation and collagen-mediated cell adhesion in sickle cell disease mice
J Thromb Haemost 2021; 20: 375 - 386
doi://10.1111/jth.15581
Kim KB et al. Alpha-linolenic acid: nutraceutical, pharmacological and toxicological evaluation
Food and Chemical Toxicology 2014; 70: 163 – 178
doi://10.1016/j.fct.2014.05.009
Takic M et al.
Effects of dietary alpha-linolenic acid treatment and the efficiency of its conversion to eicosapentaenoic and docosahexaenoic acids in obesity and related diseases
Molecules 2022; 27 (4471): 1 - 23
doi://10.3390/molecules27144471